May predict response to Imaging Research anti new crude tumor

Advanced image processing technology for patients with tumor responds to angiogenesis drug therapy, able to distinguish which one might be. Patient's brain tumor glioma risk, Massachusetts General Hospital (Dana Farber Cancer Institute component) of researchers report, for those whose treatment anti angiogenesis drug cediranib and rapidly of their tumors around of abnormal blood vessels that "normalize" and who cediranib did not increase blood flow of patients significantly the longer survival tumor in a blood flow increases and newly diagnosed. Displays the report in PNAS Early Edition.

View the original article here